{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:32:20Z","timestamp":1767706340762,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2016\/23\/N\/NZ7\/00442"],"award-info":[{"award-number":["2016\/23\/N\/NZ7\/00442"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005297","name":"Uniwersytet Medyczny w Bialymstoku","doi-asserted-by":"publisher","award":["SUB\/2\/DN\/20\/001\/2211"],"award-info":[{"award-number":["SUB\/2\/DN\/20\/001\/2211"]}],"id":[{"id":"10.13039\/501100005297","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.vaccine.2022.02.037","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T22:41:54Z","timestamp":1645051314000},"page":"1996-2002","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The effect of ChAdOx1 nCov-19 vaccine on arterial thrombosis development and platelet aggregation in female rats"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4968-4429","authenticated-orcid":false,"given":"Bartlomiej","family":"Kalaska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0958-0454","authenticated-orcid":false,"given":"Joanna","family":"Miklosz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5326-3950","authenticated-orcid":false,"given":"Justyna","family":"Swieton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8444-6816","authenticated-orcid":false,"given":"Aleksandra","family":"Jakimczuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3751-0608","authenticated-orcid":false,"given":"Dariusz","family":"Pawlak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2406-5290","authenticated-orcid":false,"given":"Andrzej","family":"Mogielnicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.02.037_b0005","unstructured":"WHO Coronavirus (COVID-19) Dashboard, https:\/\/covid19.who.int\/"},{"issue":"6","key":"10.1016\/j.vaccine.2022.02.037_b0010","doi-asserted-by":"crossref","first-page":"e2114531","DOI":"10.1001\/jamanetworkopen.2021.14531","article-title":"Comparison of COVID-19 vaccine approvals at the US Food and Drug administration, European Medicines agency, and health Canada","volume":"4","author":"Lythgoe","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1016\/j.vaccine.2022.02.037_b0015","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1016\/j.ymthe.2021.08.001","article-title":"A comprehensive analysis of the efficacy and safety of COVID-19 vaccines","volume":"29","author":"Cai","year":"2021","journal-title":"Mol Ther"},{"issue":"10269","key":"10.1016\/j.vaccine.2022.02.037_b0020","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.vaccine.2022.02.037_b0025","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.vaccine.2022.02.037_b0030","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.vaccine.2022.02.037_b0035","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMe2106315","article-title":"SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia","volume":"384","author":"Cines","year":"2021","journal-title":"N Engl J Med"},{"issue":"7873","key":"10.1016\/j.vaccine.2022.02.037_b0040","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-021-03744-4","article-title":"Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia","volume":"596","author":"Huynh","year":"2021","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.vaccine.2022.02.037_b0045","doi-asserted-by":"crossref","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLOS Biol"},{"key":"10.1016\/j.vaccine.2022.02.037_b0050","first-page":"219","article-title":"Comparison of a thromboxane receptor antagonist and aspirin in experimental arterial thrombosis","volume":"23","author":"Schumacher","year":"1993","journal-title":"Haemostasis"},{"key":"10.1016\/j.vaccine.2022.02.037_b0055","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.trsl.2016.06.009","article-title":"Heparin-binding copolymer reverses effects of unfractionated heparin, enoxaparin, and fondaparinux in rats and mice","volume":"177","author":"Kalaska","year":"2016","journal-title":"Transl Res"},{"issue":"3_Suppl","key":"10.1016\/j.vaccine.2022.02.037_b0060","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1293\/tox.29.3S-1","article-title":"Non-proliferative and proliferative lesions of the cardiovascular system of the rat and mouse","volume":"29","author":"Berridge","year":"2016","journal-title":"J Toxicol Pathol"},{"issue":"2","key":"10.1016\/j.vaccine.2022.02.037_b0065","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/0192623310396907","article-title":"Best practices for evaluation of bone marrow in nonclinical toxicity studies","volume":"39","author":"Reagan","year":"2011","journal-title":"Toxicol Pathol"},{"issue":"15","key":"10.1016\/j.vaccine.2022.02.037_b0070","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1212\/WNL.0000000000012576","article-title":"Adenovirus-Vectored COVID-19 Vaccine-Induced Immune Thrombosis of Carotid Artery: A Case Report","volume":"97","author":"Walter","year":"2021","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.vaccine.2022.02.037_b0075","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/blood.2021012217","article-title":"Frequency of positive anti-PF4\/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2","volume":"138","author":"Thiele","year":"2021","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.vaccine.2022.02.037_b0080","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1182\/blood.2021012152","article-title":"Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know","volume":"138","author":"Arepally","year":"2021","journal-title":"Blood"},{"issue":"02","key":"10.1016\/j.vaccine.2022.02.037_b0085","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1055\/s-0029-1220325","article-title":"Whole Blood Platelet Aggregometry and Platelet Function Testing","volume":"35","author":"McGlasson","year":"2009","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"10.1016\/j.vaccine.2022.02.037_b0090","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/jth.15156","article-title":"Is there a role for the ACE2 receptor in SARS-CoV-2 interactions with platelets?","volume":"19","author":"Campbell","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"21","key":"10.1016\/j.vaccine.2022.02.037_b0095","first-page":"00096","article-title":"The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia","volume":"S1050\u20131738","author":"Iba","year":"2021","journal-title":"Trends Cardiovasc Med"},{"issue":"5","key":"10.1016\/j.vaccine.2022.02.037_b0100","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/01.HYP.0000035396.27909.40","article-title":"Antithrombotic effect of captopril and losartan is mediated by angiotensin-(1\u20137)","volume":"40","author":"Kucharewicz","year":"2002","journal-title":"Hypertension"},{"issue":"06","key":"10.1016\/j.vaccine.2022.02.037_b0105","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1160\/TH04-10-0701","article-title":"Angiotensin II enhances thrombosis development in renovascular hypertensive rats","volume":"93","author":"Mogielnicki","year":"2005","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.vaccine.2022.02.037_b0110","first-page":"317","article-title":"Angiotensin-(1\u20139), the product of angiotensin I conversion in platelets, enhances arterial thrombosis in rats","volume":"61","author":"Kramkowski","year":"2010","journal-title":"J Physiol Pharmacol"},{"issue":"4","key":"10.1016\/j.vaccine.2022.02.037_b0115","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1182\/blood.2021011958","article-title":"Prothrombotic immune thrombocytopenia after COVID-19 vaccination","volume":"138","author":"Tiede","year":"2021","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.vaccine.2022.02.037_b0120","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","article-title":"Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages","volume":"20","author":"Merad","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"24","key":"10.1016\/j.vaccine.2022.02.037_b0125","doi-asserted-by":"crossref","first-page":"E913","DOI":"10.1503\/cmaj.210882","article-title":"Recognizing, managing and reporting vaccine-induced immune thrombotic thrombocytopenia","volume":"193","author":"Sholzberg","year":"2021","journal-title":"CMAJ"},{"issue":"5","key":"10.1016\/j.vaccine.2022.02.037_b0130","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/s41591-021-01329-2","article-title":"Single-cell multi-omics analysis of the immune response in COVID-19","volume":"27","author":"Stephenson","year":"2021","journal-title":"Nat Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22001736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22001736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:08:44Z","timestamp":1759403324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22001736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":26,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0264410X22001736"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.02.037","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of ChAdOx1 nCov-19 vaccine on arterial thrombosis development and platelet aggregation in female rats","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.02.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}